Average annual cost of Parkinson's disease in a Brazilian multiethnic population.

Autor: Bovolenta TM; Graduate Program, Hospital Israelita Albert Einstein, São Paulo, Brazil. Electronic address: tmb.dalmeida@gmail.com., Schumacher-Schuh AF; Department of Pharmacology, Federal University of Rio Grande do Sul, Porto Alegre, Brazil. Electronic address: schuh.afs@gmail.com., Santos-Lobato BLD; Center of Biological and Health Sciences, Federal University of Pará, Belém, Pará, Brazil. Electronic address: bruls4@ufpa.br., Godeiro Júnior CO; Internal Medicine Department, Federal University of Rio Grande do Norte, Natal, RN, Brazil. Electronic address: godeirojunior@gmail.com., Silva DJD; Neuroscience Core, Hospital Clinics, Federal University of Goiás, Brazil Integrated Neurosciences Institute, Goiás, Brazil. Electronic address: delson@iineuro.com.br., Nicaretta D; School of Medicine and Surgery - UNIRIO HUGG/EBSERH Rio de Janeiro, Brazil. Electronic address: denise.ntg@terra.com.br., Barbosa ER; Movement Disorders Clinic, Department of Neurology, School of Medicine of the University of São Paulo, São Paulo, SP, Brazil. Electronic address: egbertob@8415.com.br., Cardoso FEC; Movement Disorders Unit Hospital das Clínicas, Federal University of Minas Gerais, Belo Horizonte, Brazil. Electronic address: fecardosoc@gmail.com., Della Coletta MV; University Hospital Getúlio Vargas, Federal University of Amazonas, Amazonas, Brazil. Electronic address: neurocoletta@ig.com.br., Braga Neto P; Department of Clinical Medicine, Neurology Section, Federal University of Ceará, Ceará, Brazil. Electronic address: pbraganeto@gmail.com., Cury RG; Movement Disorders Center, Department of Neurology, School of Medicine, University of São Paulo, São Paulo, Brazil. Electronic address: rubens.cury@hc.fm.usp.br., Tumas V; Department of Neuroscience and Sciences of Behavior, Division of Neurology, Faculty of Medicine of Ribeirão Preto, University of São Paulo, São Paulo, Brazil. Electronic address: tumasv@fmrp.usp.br., Felicio AC; Department of Neurology and Brain Institute, Hospital Israelita Albert Einstein, São Paulo, Brazil. Electronic address: andre.felicio@einstein.br.
Jazyk: angličtina
Zdroj: Parkinsonism & related disorders [Parkinsonism Relat Disord] 2023 Dec; Vol. 117, pp. 105897. Date of Electronic Publication: 2023 Oct 21.
DOI: 10.1016/j.parkreldis.2023.105897
Abstrakt: Introduction: With the current demographic transition, it is estimated that by 2050 Brazil will have a population of 90 million people aged 60 years or more, and in parallel Parkinson's disease (PD) will bring a considerable economic burden to our society. Brazil is considered multiracial due to its colonization, generating important social and regional inequalities. Knowing the costs of the PD may aid to improve local public policies. However, in Brazil, no estimates of these values have been made so far.
Objectives: To evaluate direct, indirect, and out-of-pocket costs in Brazilian people with PD (PwP).
Methods: Categorical and numerical data were collected through a customized and standardized cost-related-questionnaire from 1055 PwP nationwide, from 10 tertiary movement disorders centers across all Brazilian regions.
Results: The estimated average annual cost of PwP was US$ 4020.48. Direct and indirect costs accounted for 63% and 36% of the total, respectively, and out-of-pocket costs were 49%. There were no evidence of differences in the total cost of PD across the regions of the country; however, differences were reported between the stages of the Hoehn and Yahr scale (H&Y).
Conclusion: This data suggests a considerable burden of PD for Brazilian society in general, not only for the public health system, but mainly for those with PD.
Competing Interests: Declaration of competing interest We wish to confirm that there are no known conflicts of interest associated with this publication and there has been no significant financial support for this work that could have influenced its outcome. We confirm that the manuscript has been read and approved by all named authors and that there are no other persons who satisfied the criteria for authorship but are not listed. We further confirm that the order of authors listed in the manuscript has been approved by all of us. We confirm that we have given due consideration to the protection of intellectual property associated with this work and that there are no impediments to publication, including the timing of publication, with respect to intellectual property. In so doing we confirm that we have followed the regulations of our institutions concerning intellectual property. We understand that the Corresponding Author is the sole contact for the Editorial process (including Editorial Manager and direct communications with the office). He is responsible for communicating with the other authors about progress, submissions of revisions and final approval of proofs. We confirm that we have provided a current, correct email address which is accessible by the Corresponding Author, and which has been configured to accept email from cf.andre@gmail.comandre.felicio@einstein.br (Andre Carvalho Felício).
(Copyright © 2023 The Authors. Published by Elsevier Ltd.. All rights reserved.)
Databáze: MEDLINE
Externí odkaz: